๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial

โœ Scribed by Peter Heald; Marilyn Mehlmauer; Ann G Martin; Constance A Crowley; Richard C Yocum; Steven D Reich

Book ID
117393729
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
328 KB
Volume
49
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

RESEARCH REPORT Bexarotene capsules and
RESEARCH REPORT Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: Results of the Australian patients treated on phase II trials
โœ H Miles Prince; Christopher McCormack; Gail Ryan; Christopher Baker; Harvey Rots ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 54 KB

## SUMMARY Bexarotene (Targretin^ยฎ^, LGD1069) is a novel synthetic retinoid analogue that binds selectively to retinoid X receptors. We describe eight previously treated patients who entered phase II international multicentre studies examining the role of bexarotene in cutaneous Tโ€cell lymphoma. Pa